Literature DB >> 11959068

Rhabdomyolysis with acute renal failure probably related to the interaction of atorvastatin and delavirdine.

Jose G Castro, Luis Gutierrez.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11959068     DOI: 10.1016/s0002-9343(01)01135-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  7 in total

Review 1.  Drug interactions between antiretroviral drugs and comedicated agents.

Authors:  Monique M R de Maat; G Corine Ekhart; Alwin D R Huitema; Cornelis H W Koks; Jan W Mulder; Jos H Beijnen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Differential effects of tipranavir plus ritonavir on atorvastatin or rosuvastatin pharmacokinetics in healthy volunteers.

Authors:  P A Pham; C J L la Porte; L S Lee; R van Heeswijk; J P Sabo; M M Elgadi; P J Piliero; P Barditch-Crovo; E Fuchs; C Flexner; D W Cameron
Journal:  Antimicrob Agents Chemother       Date:  2009-08-10       Impact factor: 5.191

Review 3.  Acute kidney injury in HIV-infected patients.

Authors:  Sahir Kalim; Lynda A Szczech; Christina M Wyatt
Journal:  Semin Nephrol       Date:  2008-11       Impact factor: 5.299

Review 4.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

5.  Rhabdomyolysis after ezetimibe/simvastatin therapy in an HIV-infected patient.

Authors:  Noemie Chanson; Philippe Bossi; Luminita Schneider; Edward Bourry; Hassane Izzedine
Journal:  NDT Plus       Date:  2008-06

6.  The Relationship Between HIV Infection and Cardiovascular Disease.

Authors:  Birgitt Dau; Mark Holodniy
Journal:  Curr Cardiol Rev       Date:  2008-08

Review 7.  Cardiovascular Risk Management and Hepatitis C: Combining Drugs.

Authors:  Elise J Smolders; Peter J G Ter Horst; Sharon Wolters; David M Burger
Journal:  Clin Pharmacokinet       Date:  2019-05       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.